USFDA approves Pfizer supplemental New Drug Application for EUCRISA (crisaborole) ointment for children with eczema Medical Dialogues Bureau29 March 2020 11:27 AM ISTAD is a chronic skin disease characterized by inflammation of the skin and skin barrier defects
Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020: CFO Medical Dialogues Bureau17 Jan 2020 12:45 PM ISTSan Francisco: Eli Lilly and Co aim to announce roughly one $1 billion (765 million pounds) to $5 billion (3.8 billion pounds) deal every quarter in...
Regeneron, Sanofi asthma drug data fails to excite investors Ruby Khatun Khatun13 Sept 2017 1:42 PM ISTPARIS: Shares of Regeneron Inc and Sanofi SA slid on Monday after late-stage trial data for their asthma drug, dupilumab, fell short of investor...
